论文部分内容阅读
目的观察经鼻持续气道正压通气(NCPAP)治疗儿童重症肺炎合并呼吸衰竭的临床效果。方法选择于2012年5月-2015年5月医院收治的重症肺炎并呼吸衰竭患儿110例,将其平均分为研究组和对照组各55例。对照组给予普通面罩吸氧,研究组应用NCPAP治疗。比较2组临床效果及血气指标。结果研究组治疗后PO2、p H均高于对照组(P<0.05),PCO2低于对照组(P<0.05)。研究组总有效率为94.55%高于对照组的81.82%,差异有统计学意义(P<0.05)。结论 NCPAP治疗儿童重症肺炎合并呼吸衰竭疗效确切,可以改善患儿的临床症状与通气功能,适于应用与推广。
Objective To observe the clinical effect of nasal continuous positive airway pressure (NCPAP) treatment of severe pneumonia in children with respiratory failure. Methods From May 2012 to May 2015, 110 children with severe pneumonia and respiratory failure admitted to our hospital were divided equally into 55 cases in study group and control group respectively. The control group were given general mask oxygen, the study group applied NCPAP treatment. The clinical effects and blood gas indexes of two groups were compared. Results After treatment, PO2 and p H in study group were higher than those in control group (P <0.05), and PCO2 was lower than that in control group (P <0.05). The total effective rate was 94.55% in the study group and 81.82% in the control group, with significant difference (P <0.05). Conclusion NCPAP treatment of severe pneumonia complicated with respiratory failure in children with exact effect, can improve the clinical symptoms and ventilation in children with function, suitable for application and promotion.